Print

bluebird bio to Present at Cowen and Company 32nd Annual Health Care Conference  
2/28/2012 6:36:47 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, a leader in the development of innovative gene therapies for severe genetic disorders, announced today that Nick Leschly, chief executive officer, is scheduled to present at the Cowen and Company 32nd Annual Health Care Conference on Tuesday, March 6, 2012 at 8:30a.m. EST at the Boston Marriott Copley Place.
//-->